A N Békássy - Concepedia

Author

A N Békássy

Lund University

Also Known As

A Bekassy, A Békassy, A Békàssy, A Békássy, A N Békássy, A. Bekassy, A. BÉKASSY, A. Békassy, A. Békássy, A. N. Bekassy

Publications

Citations

H-Index

Concepts

All Affiliations

Lund University Uppsala University Hospital Integrated Cardio Metabolic Centre Uppsala University Karolinska University Hospital

About

A N Békássy is an author at Lund University specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	973
2	Health Sciences	2	2	183
3	Natural Sciences	1	1	21
4	Public Health	1	1	104
5	Biochemistry	1	1	65

A N Békássy

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation Anna Locasciulli, Rosi Oneto, Almalina Bacigalupo, Haematologica	2007	317
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation André Tichelli, Jakob Passweg, Dorota Wójcik, Haematologica	2008	175
Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. A N Békássy, J Hermans, Norbert Claude Gorin, PubMed Hematological MalignancyTransplantationMarrow TransplantationGranulocytic SarcomaMedicine	1996	171
Busulfan bioavailability Moustapha Hassan, Per Ljungman, P Bolme, Blood	1994	167
Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology Moustapha Hassan, Göran Berg, A N Békássy, Cancer Chemotherapy and Pharmacology PharmacologyHigh-dose BusulphanClinical PharmacologyPharmacotherapyMedicine	1991	155
The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity Moustapha Hassan, Per Ljungman, Olle Ringdén, Bone Marrow Transplantation Pharmacological Study4-Hydroxy MetaboliteMedicineTime Interval InfluenceToxicology	2000	148
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene Mario Wijker, Sarah Herterich, CGM van Berkel, European Journal of Human Genetics BiologyGenetic AnalysisHeterogeneous SpectrumAllelic VariantGenetic Disorder	1999	104
Recent improvement in outcome of unrelated donor transplantation for aplastic anemia Romaine Viollier, Gèrard Socié, André Tichelli, Bone Marrow Transplantation TransplantationBone Marrow FailureHematologyUnrelated Donor TransplantationGraft Survival	2007	91
A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42 Kajsa Paulsson, A N Békássy, Tor Olofsson, Leukemia Hematological MalignancyMedicineHematologyImmunologyAdult T-cell Leukemia-lymphoma	2005	72
Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients Marie Sandström, MO Karlsson, Per Ljungman, Bone Marrow Transplantation TransplantationDose IndividualizationHematologyPharmacologyStem Cell Transplantation	2001	69

Page 1